Trials / Completed
CompletedNCT02386982
Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
A Single-centre, Randomized, Open-label, 2-arm, 4-week Treatment Study to Investigate the Beta Cell Function and Related Pharmacodynamics in Type 2 Diabetes Mellitus (T2DM) Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Hua Medicine Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the beta cell function, pharmacodynamics, pharmacokinetics, safety and tolerability after 4 weeks treatment of 75mgBID or 75mgQD of HMS5552.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HMS5552 |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2015-03-12
- Last updated
- 2015-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02386982. Inclusion in this directory is not an endorsement.